LifeMD, Inc. (LFMDP) Return on equity 2017–2025
LifeMD, Inc. (LFMDP) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
62.0%FY2025 · since FY2017: -136.7% → 62.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 62.0% | — |
| FY2023 | -587.6% | — |
| FY2021 | -267.8% | — |
| FY2018 | -138.2% | -1.5 pp |
| FY2017 | -136.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More LFMDP financial trends
LFMDP RevenueLFMDP Net incomeLFMDP Net marginLFMDP Gross profitLFMDP Gross marginLFMDP Operating incomeLFMDP Operating marginLFMDP Operating cash flowLFMDP Free cash flowLFMDP Capital expendituresLFMDP Stock buybacksLFMDP Dividends paidLFMDP Total assetsLFMDP Total liabilitiesLFMDP Shareholders’ equityLFMDP overview →